Company Filing History:
Years Active: 2009-2012
Title: The Innovations of Wenbin Ma
Introduction
Wenbin Ma is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly through his innovative work on antigenic peptides.
Latest Patents
Wenbin Ma holds two patents, both related to MAGE-C2 antigenic peptides. His inventions focus on isolated peptides derived from MAGE-C2, nucleic acid molecules that encode MAGE-C2, and expression vectors comprising these nucleic acid molecules. The patents also cover host cells transformed or transfected with the nucleic acid molecules or expression vectors, as well as tetramers that include the peptides, HLA molecules, beta-microglobulin, and binding partners. These inventions are crucial for developing methods that utilize the peptides and nucleic acid molecules, as well as for creating cytolytic T cells that recognize the peptides in complex with HLA molecules.
Career Highlights
Wenbin Ma is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research in cancer immunotherapy. His work has the potential to significantly impact the treatment of cancer by enhancing the immune response against tumor cells.
Collaborations
Wenbin collaborates with esteemed colleagues such as Benoit Van Den Eynde and Thierry R Boon-Falleur, contributing to a rich environment of innovation and research.
Conclusion
Wenbin Ma's contributions to the field of cancer research through his patents on MAGE-C2 antigenic peptides highlight his role as a leading inventor in this critical area. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.